The Biotech Age: The Business of Biotech and How to Profit from It

ISBN-13: 9780071414890 / Angielski / Miękka / 2003 / 256 str.

Richard W. Oliver

Opis

Since The Coming BioTech Age was published in 1999, much has changed in this fast-moving, volatile industry. Furthermore, media attention on biotech, especially ethical and legislative issues, has increased several times over. Biotech companies are featured regularly in business publications and general interest magazines and newspapers are running stories on cloning and stem cell research on an almost daily basis. Major developments that have taken place since the book was published, The human genome was mapped by Celera Genomics in June, 2000, well ahead of schedule, just a few months after a rough draft was finished. Stem cell research has become front-page news, with debates in Congress, the White House, and the public forums being hotly contested. The politically powerful Right to Life camp has split down the middle on the issue. Funding and investment in biotech have increased at a rapid pace, with the tech meltdown having little effect on the biotech environment. Market capitalization increased from USD138 billion when the book was written to over USD330 billion in 2001, despite declines in the overall markets. There are now more than 350 biotech drugs and vaccines in clin